Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response
Srikanta Dash,1,2 Srinivas Chava,1 Partha K Chandra,1 Yucel Aydin,2 Luis A Balart,2 Tong Wu1 1Department of Pathology and Laboratory Medicine, 2Department of Gastroenterology and Hepatology, Tulane University School of Medicine, New Orleans, LA, USA Abstract: Autophagy is an intracellular lysosomal...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f0d2280ef3934939957b0585dde38b5c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f0d2280ef3934939957b0585dde38b5c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f0d2280ef3934939957b0585dde38b5c2021-12-02T07:44:39ZAutophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response1179-1535https://doaj.org/article/f0d2280ef3934939957b0585dde38b5c2016-02-01T00:00:00Zhttps://www.dovepress.com/autophagy-in-hepatocellular-carcinomas-from-pathophysiology-to-therape-peer-reviewed-article-HMERhttps://doaj.org/toc/1179-1535Srikanta Dash,1,2 Srinivas Chava,1 Partha K Chandra,1 Yucel Aydin,2 Luis A Balart,2 Tong Wu1 1Department of Pathology and Laboratory Medicine, 2Department of Gastroenterology and Hepatology, Tulane University School of Medicine, New Orleans, LA, USA Abstract: Autophagy is an intracellular lysosomal degradation process performed by the cells to maintain energy balance. The autophagy response plays an important role in the progression of liver disease due to hepatitis virus infection, alcoholic liver disease, nonalcoholic fatty liver disease, liver cirrhosis, and hepatocellular carcinoma (HCC). An increased autophagy response also contributes to the pathogenesis of liver disease through modulation of innate and adaptive immune responses; a defective cellular autophagy response leads to the development of HCC. Recent progress in the field indicates that autophagy modulation provides a novel targeted therapy for human liver cancer. The purpose of this review is to update our understanding of how the cellular autophagy response impacts the pathophysiology of liver disease and HCC treatment. Keywords: hepatocellular carcinoma, macroautophagy, microautophagy, autophagy inhibitor, chloroquine, hydroxychloroquine, sorafenibDash SChava SChandra PKAydin YBalart LAWu TDove Medical Pressarticlehepatocellular carcinomamacroautophagymicroautophagyautophagy inhibitorchloroquinehydroxychloroquinesorafenibDiseases of the digestive system. GastroenterologyRC799-869ENHepatic Medicine: Evidence and Research, Vol 2016, Iss Issue 1, Pp 9-20 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
hepatocellular carcinoma macroautophagy microautophagy autophagy inhibitor chloroquine hydroxychloroquine sorafenib Diseases of the digestive system. Gastroenterology RC799-869 |
spellingShingle |
hepatocellular carcinoma macroautophagy microautophagy autophagy inhibitor chloroquine hydroxychloroquine sorafenib Diseases of the digestive system. Gastroenterology RC799-869 Dash S Chava S Chandra PK Aydin Y Balart LA Wu T Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response |
description |
Srikanta Dash,1,2 Srinivas Chava,1 Partha K Chandra,1 Yucel Aydin,2 Luis A Balart,2 Tong Wu1 1Department of Pathology and Laboratory Medicine, 2Department of Gastroenterology and Hepatology, Tulane University School of Medicine, New Orleans, LA, USA Abstract: Autophagy is an intracellular lysosomal degradation process performed by the cells to maintain energy balance. The autophagy response plays an important role in the progression of liver disease due to hepatitis virus infection, alcoholic liver disease, nonalcoholic fatty liver disease, liver cirrhosis, and hepatocellular carcinoma (HCC). An increased autophagy response also contributes to the pathogenesis of liver disease through modulation of innate and adaptive immune responses; a defective cellular autophagy response leads to the development of HCC. Recent progress in the field indicates that autophagy modulation provides a novel targeted therapy for human liver cancer. The purpose of this review is to update our understanding of how the cellular autophagy response impacts the pathophysiology of liver disease and HCC treatment. Keywords: hepatocellular carcinoma, macroautophagy, microautophagy, autophagy inhibitor, chloroquine, hydroxychloroquine, sorafenib |
format |
article |
author |
Dash S Chava S Chandra PK Aydin Y Balart LA Wu T |
author_facet |
Dash S Chava S Chandra PK Aydin Y Balart LA Wu T |
author_sort |
Dash S |
title |
Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response |
title_short |
Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response |
title_full |
Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response |
title_fullStr |
Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response |
title_full_unstemmed |
Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response |
title_sort |
autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response |
publisher |
Dove Medical Press |
publishDate |
2016 |
url |
https://doaj.org/article/f0d2280ef3934939957b0585dde38b5c |
work_keys_str_mv |
AT dashs autophagyinhepatocellularcarcinomasfrompathophysiologytotherapeuticresponse AT chavas autophagyinhepatocellularcarcinomasfrompathophysiologytotherapeuticresponse AT chandrapk autophagyinhepatocellularcarcinomasfrompathophysiologytotherapeuticresponse AT aydiny autophagyinhepatocellularcarcinomasfrompathophysiologytotherapeuticresponse AT balartla autophagyinhepatocellularcarcinomasfrompathophysiologytotherapeuticresponse AT wut autophagyinhepatocellularcarcinomasfrompathophysiologytotherapeuticresponse |
_version_ |
1718399255248371712 |